Skip main navigation

Targeted antimicrobial therapy for urinary sepsis: Case #2

In this step we explore the antimicrobial therapy options for Bill Jenkins.
Hand with pills

Mr Jenkins was administered meropenem 2g TID and amikacin 1g QD.

Forty-eight hours later he still has a high temperature but his overall clinical condition and the analytical data show frank improvement. No alternative source of infection has been found and his urine and blood cultures have come back positive with a phenotypically identical E. coli in both.

Blue table with three columns: Antibiotic/MIC (ug/mL)/Interpretation. There are 14 antibiotics listed with their MIC and Susceptibility or Resistance noted

The question now is how would you continue antimicrobial therapy?

There are several options but before going into the therapeutic options let’s summarise the case:

  • Mr Jenkins had a (severe) urinary sepsis and we have good evidence of the etiological agent: an ESBL-producing E. coli.

  • Although he is still febrile, the clinical course is favourable.

  • No evidence of abscess or urinary obstruction has been found.

This article is from the free online

Challenges in Antibiotic Resistance: Gram Negative Bacteria

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education